Herein, we review the existing evidence and illustrate the neuroprotective pathways that are induced following GLP-1R activation in neurons, microglia and astrocytes
The program took effect July 1, 2026 and runs through December 31, 2027
Another 2016 study focused on Semaglutide in patients with type 2 diabetes, many of whom also had cardiovascular disease, kidney disease, or both
Patients in their 40s, 50s, and 60s often hit a metabolic wall: weight gain that did not happen at 30, fasting glucose climbing into the high-90s or low-100s, fatigue that does not match their workload, and a feeling that their body is no longer responding to the things that used to keep them lean
Although many products claim to contain beneficial peptides, not all are created equal
doi: 10.1016/S2213-8587(15)00134-5